Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (19) Remove All (19) filter
  • News & Articles (9)
  • Research (5)
  • Researcher Profiles (4)
  • General (1)

Search found 19 items

All
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial
Category: Research
Research Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial ...
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial
Category: Research
Research Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial ...
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial
Category: Research
Research Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) trial ...
Chris Levi
Category: Researcher Profiles
... of stroke. Stroke, Trans Ischemic Attacks, TIA, stroke therapy, Alteplase, Tenecteplase, brain imaging, CT scans, MRI, Professor Chris ...
Hunter-led advances in acute stroke care will change clinical practice
Category: News & Articles
... standard thrombolytic, recombinant tissue plasminogen activator (Alteplase). The standard clot-dissolving agent Alteplase is a proven effective treatment for acute ischaemic stroke – ... in 3 patients we treat. This is because of two main reasons: Firstly, Alteplase takes too long to dissolve the clot and this leads to more ...
New Therapies Save Stroke Patient From Double Trouble
Category: News & Articles
... two strokes and I’m still here.” * The TASTE (Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation) trial is supported by the ... in the Hunter. Stroke, Stroke research, TASTE, Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation New Therapies Save Stroke ...
Mark Parsons
Category: Researcher Profiles
... Tenecteplase was superior to the standard therapy for stroke, Alteplase. He has led clinical trials in this area with very promising ...
Neil Spratt
Category: Researcher Profiles

What are your research interests?

  • New treatments for stroke
Landmark Hunter study shows dramatic benefit of new stroke therapy
Category: News & Articles
... months after their stroke. Of those administered the standard drug Alteplase (tPA) during the trial from 2008-2011, only 36 per cent showed ... resulted in impressive benefits over the standard treatment with Alteplase,” study leader Associate Professor Mark Parsons from the University of Newcastle* said. “With Alteplase we have seen a few dramatic outcomes but using a higher dosage ...
Battle of the clot-busters in international stroke trial
Category: News & Articles
... commonly used for heart attacks, over the standard stroke treatment Alteplase in a broader group of stroke victims. The study has been dubbed TASTE (Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation). Results from the Phase II ... within a day, compared with 36 per cent for those administered Alteplase. “Using Tenecteplase we’ve seen patients severely affected ...
  • 1
  • 2
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services